Adaptive Biotechnologies (ADPT) Capital Leases (2019)
Adaptive Biotechnologies' (ADPT) quarterly Capital Leases came in at $36.6 million in Q4 2019, up 56.11% quarter-over-quarter from $23.4 million in Q3 2019.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Capital Leases (2019) Analysis & Trends
Adaptive Biotechnologies has disclosed Capital Leases across 1 years of filings, most recently posting $36.6 million for Q4 2019.
- In Q4 2019, Capital Leases changed N/A year-over-year to $36.6 million; the TTM figure through Dec 2019 stood at $36.6 million (changed N/A YoY), while the FY2019 annual figure was $36.6 million, changed N/A from the prior year.
- Capital Leases came in at $36.6 million for Q4 2019 at Adaptive Biotechnologies, up from $23.4 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $36.6 million in Q4 2019 to a low of $23.4 million in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |